Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 06-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 5,210 | N/A |
| Receivables | N/A | N/A | N/A | 1,610 | N/A |
| Inventories | N/A | N/A | N/A | 180 | N/A |
| Other current assets | 0 | 0 | 0 | 750 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $7,750 | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 3,660 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $3,660 | $N/A |
| Total Assets | $N/A | $N/A | $N/A | $14,920 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 240 | N/A |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 1,510 | 0 |
| Accrued Expenses | N/A | N/A | N/A | 1,080 | N/A |
| Other current liabilities | N/A | N/A | N/A | 350 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $3,490 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 1,480 | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 250 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $2,340 | $N/A |
| Total Liabilities | $N/A | $N/A | $N/A | $5,850 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 1,980 | N/A |
| Retained earnings | N/A | N/A | N/A | -47,050 | N/A |
| Other shareholders' equity | 0 | 0 | 0 | -5,170 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $9,060 | $N/A |
| Total Liabilities And Equity | $0 | $0 | $0 | $14,910 | $0 |